Aricept

 / 
( donepezil )
Aricept
Aricept
Brand
$47.53
$40.21
Price/unit: $1.44
Shipped from: United Kingdom, Switzerland, Turkey, Germany
FDA Status: Discontinued
Zelle

Pay securely with Zelle

Description

Aricept is a medication classified as a cholinesterase inhibitor, used to treat mild to moderate Alzheimer's disease. It is administered as an oral tablet and is available by prescription only. Patients are advised to be cautious as Aricept may cause gastrointestinal side effects, including nausea and diarrhea, and should be used with caution in patients with a history of asthma or obstructive pulmonary disease.

US Market Context: Namzaric Combination Capsule Discontinuation

According to official drug supply notifications under Section 506C of the FD&C Act, domestic market availability for single-capsule fixed-dose combinations of Donepezil Hydrochloride and Memantine Hydrochloride Extended-Release (formerly marketed as Namzaric) faces permanent manufacturing discontinuations and supply holds across U.S. distribution channels.

Because cholinesterase inhibitors and NMDA receptor antagonists form the clinical foundation for managing moderate-to-severe dementia of the Alzheimer's type, unexpected product withdrawals present critical continuity challenges for caregivers and families. While fixed-dose combination capsules face market exit, independent international supplies of the individual active components—specifically Aricept (Donepezil) and Namenda (Memantine) oral tablets—remain stable and fully accessible.

Dual-Tablet Substitution Protocol

When transitioning care plans following a combination drug withdrawal, maintaining active pharmacological coverage is essential:

  • US Discontinuation Focus: Permanent market holds directly impact single daily fixed-dose combination capsules containing both Memantine ER and Donepezil HCl.

  • Dual-Tablet Alternative: Profarma Express facilitates access to authentic, batch-certified Aricept (Donepezil HCl) and Namenda (Memantine HCl) oral solid tablets sourced directly from accredited European partner pharmacies.

IMPORTANT MEDICAL NOTICE: Transitioning a patient from a single combination capsule to a dual-tablet regimen (taking individual Aricept and Namenda tablets concurrently) delivers bioequivalent active drug exposure. However, dosing schedules, active component titration, and administration timing must be evaluated and approved by the attending neurologist or primary care physician.

⚠️ IMPORTANT SAFETY WARNING: CARDIOVASCULAR & GASTROINTESTINAL RISKS

Donepezil (Aricept), as a cholinesterase inhibitor, may have vagotonic effects on the sinoatrial and atrioventricular nodes, manifesting as bradycardia or heart block in both patients with and without underlying cardiac conduction abnormalities. Additionally, monitor patients closely for active or occult gastrointestinal bleeding, especially those with a history of ulcer disease or concurrent NSAID use.

Clinical Applications & Administration Differences

While combination capsules provided a single daily dose, individual oral tablets allow precise dose adjustment for each active ingredient, accommodating renal impairment or dose-titration requirements:

Formulation

Primary Clinical Use

US FDA Supply Status

International Availability

Namzaric Combination Capsule

Single-Dose Dual Maintenance

⚠️ Discontinued / Market Exit

Restricted Clinical Stock

Aricept + Namenda Tablets

Dual-Tablet Co-Administration

Active Component Availability

✅ In Stock & Ready to Ship

Quality Assurance & Personal Importation Integrity

  • Authentic Sourcing: Genuine branded Aricept and Namenda tablets dispensed exclusively by licensed UK and European Union partner pharmacies.

  • Prescription Verification: Every order undergoes rigorous verification against a valid medical prescription by supervising licensed pharmacists.

  • Tracked Logistics: Temperature-monitored international shipping delivered directly to all 50 U.S. states.

Domestic U.S. market availability of the combination capsule has been impacted by permanent manufacturer discontinuations under Section 506C FD&C Act notifications, active ingredient sourcing reallocation, and distribution holds.

Yes, under direct physician supervision. Taking Aricept (Donepezil) and Namenda (Memantine) as separate daily tablets provides the exact same active pharmaceutical agents to manage Alzheimer's symptoms. Your healthcare provider will confirm appropriate strength matching.

Yes. Both Aricept and Namenda are prescription-only cognitive therapies requiring active clinical oversight. Valid medical prescriptions from a licensed healthcare provider are strictly required to process your order.

Under U.S. FDA personal importation enforcement discretion, U.S. residents facing domestic drug shortages or product discontinuations generally encounter no enforcement objections when importing up to a 90-day supply of essential personal prescription medications for non-commercial use, provided a valid prescription is verified by a licensed healthcare provider.

Track Other Monitored FDA Drug Deficits

🍪 We use cookies

We use cookies to enhance your browsing experience, serve personalised content, and analyse traffic. By clicking "Accept all", you consent to our use of cookies.